Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Spyros A. Kalams, MD
Vanderbilt University
Study Chair - Stephen De Rosa, MD
Fred Hutchinson Cancer Research Center and University of Washington
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alabama Vaccine Crs
Birmingham, Alabama, United States
- San Francisco Vaccine and Prevention Crs
San Francisco, California, United States
- Hiv Prevention & Treatment Crs
New York, New York, United States
- Ny Blood Ctr./union Square Crs
New York, New York, United States
- Univ. of Rochester Hvtn Crs
Rochester, New York, United States
- Vanderbilt Vaccine Crs
Nashville, Tennessee, United States
- Fhcrc/uw Vaccine Crs
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2006
- Primary completion
- —
- Completion
- 31 Aug 2007
- Last update posted
- 14 Oct 2021
- Registered enrollment
- 66
- Registry id
- NCT00270218
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.